Beranda › Narkolepsi › Ohio
Uji klinis Narkolepsi di Ohio
7 studi untuk Narkolepsi mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Cincinnati, Ohio, Cincinnati
- Dublin, Ohio, Dublin
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cincinnati
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Intrepid Research, LLC, Cincinnati
- The Cleveland Clinic Foundation, Cleveland
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07675135A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Intrepid Research, Cincinnati
- Ohio Sleep Medicine and Neuroscience Institute, Dublin
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- dan 1 lainnya
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Takeda Site 13, Cincinnati
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07633301A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07096674Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.